In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Select congresses

    Select Select congresses(s)

  • Year

    Select Year(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • Select congresses
  • sub-topic
  • Year
  • Resource type
  • Topic
  • Select congresses
  • sub-topic
  • Year
  • Resource type
  • Topic

Sponsored content

Presentations below are part of sessions sponsored by Novartis Pharma AG

56 results for your search

How to achieve the optimisation we aim for.

Congress : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Novartis

Optimising treatment for patients in the vulnerable phase.

Congress : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : J Butler (Atlanta,US)
  • Sponsored by Novartis

Panel discussion - Making critical choices for patients at the right time.

Congress : Heart Failure 2019

  • Session : Making critical choices for patients at the right time - Join the discussion
  • Speaker : F Ruschitzka (Zurich,CH), J McMurray (Glasgow,GB), M Senni (Bergamo,IT), J Butler (Atlanta,US)
  • Sponsored by Novartis

Panel discussion - Treatment choices to optimise benefits for heart failure patients.

Congress : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : F Ruschitzka (Zurich,CH), J McMurray (Glasgow,GB), M Senni (Bergamo,IT), J Butler (Atlanta,US)
  • Sponsored by Novartis

Personalising care for heart failure patients.

Congress : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : J McMurray (Glasgow,GB)
  • Sponsored by Novartis

Summary and conclusion - Treatment choices to optimise benefits for heart failure patients.

Congress : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : J McMurray (Glasgow,GB)
  • Sponsored by Novartis

Welcome and introduction - Treatment choices to optimise benefits for heart failure patients.

Congress : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Novartis

Welcome video.

Congress : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Sponsored by Novartis

Audience Q&A and panel discussion.

Congress : ESC Congress 2018

  • Session : Emerging evidence-based approaches to reduce residual atherosclerotic risk
  • Speaker : W Koenig (Munich,DE), P Libby (Boston,US), PM Ridker (Boston,US), JH Cornel (Alkmaar,NL)
  • Sponsored by Novartis Pharma AG

Case 2: My HF patient post-hospitalization is easy to manage!

Congress : Heart Failure 2018

  • Session : Heart failure case debates with the experts
  • Speaker : CS Lam (Singapore,SG), J Cleland (Glasgow,GB)
  • Organised by Medscape Education, supported with an educational grant by Novartis

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are